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ABSTRACT
INTRODUCTION AND LITERATURE
New technology presents difficulties for policy makers in that it is impossible to
determine every subsequent impact of a novel technology when it is introduced to
society. Direct-to-consumer (DTC) genetic testing exemplifies this problem while
presenting the additional complication of having an impact on both individual and public
health. Little research has been done on what consumer perceptions of information
presented to them are. Some studies have demonstrated a need for further work and
expert consensus has identified issues with advertisements but no research has been
done on consumer perceptions.

METHODOLOGY
A cohort of faculty and staff at the Rochester Institute of Technology (RIT) were
presented with a screenshot of a website from a leader in the DTC genetic testing
industry and asked about their perceptions of the genetic tests presented on that page.
The survey was distributed via email and presented using RIT Clipboard software.

RESULTS AND DISCUSSION
103 responses to the survey were received and analyzed. There was a wide range in the
answers provided to questions but several themes emerged upon analysis. This
population was significantly more educated than the general U.S. population. Many
respondents indicated some form of knowledge in science and or technology, either
through formal education or work experience. The responses indicated a significant lack
of understanding of the information presented by the company. Some respondents
demonstrated a misunderstanding of the basic concepts underlying the information
presented and a failure to correctly interpret the advertisement. These results indicate a
potential need for policies regarding the structure, content and interpretation of these
advertisements. Further research should focus on establishing similar results for other
genetic tests and DTC genetic testing companies as well as developing methodologies to
assess retention of information and economic and political acceptance of potential
regulation.
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INTRODUCTION
In any field, new technology presents substantial difficulties to policy makers. When
the public’s health can be impacted by a new technology, those difficulties can become
real and immediate threats to public well-being. As medical technology continues to
advance, policy needs to be continually updated to deal with the new benefits and
possible drawbacks to each development. Within this arena, genetic testing has become
an issue which has advanced to a point where there may be need for government
oversight. Among the promises of genetic testing are better health outcomes for patients
due to improved clinical treatment. The eventual goal of utilizing this information is to
improve patients’ quality of life and to increase longevity. However, the benefits and
costs of genetic testing are difficult to determine and many factors complicate the
clinical treatment of patients. Direct-to-consumer (DTC) genetic testing presents an
additional problem in that a large amount of complex information is made available to
the consumer without the interpretational assistance of a trained professional. There are
concerns regarding multiple aspects of these tests and there is little oversight from the
federal government of the tests and the surrounding issues. This lack of oversight may
eventually lead to poorer outcomes for patients and an increased burden on the
healthcare system.

Genetic testing is a process by which a specific mutation or mutations are identified in
the genome of an individual. In a clinical setting these tests should lead to a diagnosis of
a specific disorder or influence a treatment decision. There are two key indicators of
whether a genetic test is useful. Analytic validity is the ability of the test to accurately
identify the specific mutation for which it was designed. Clinical validity means that the
mutation being tested for has an impact on the how the patient’s treatment and can
positively influence a health outcome.

A genetic test which demonstrates both of these qualities is that for Hereditary Nonpolyposis Colorectal Cancer (HNPCC) gene. The presence of this gene indicates an
approximately 80% chance of developing colorectal cancer. The increased risk is
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demonstrative of the tests analytic validity. The identification of a family history and
subsequent testing for and discovery of this gene alter the course of screening for
carriers. Normally an individual is recommended for screening every ten years,
beginning at age 40 for colorectal cancer. However, if a patient is identified as having
the HNPCC mutation, they should begin screening between ages 20 to 25 and continue
to be screened every one to three years. This change in screening demonstrates clinical
validity. The added genetic knowledge is beneficial because it increases screening
procedures which may find a tumor at an earlier stage, increasing the likelihood of a
positive outcome for the patient. (Rex, Johnson, Lieberman, Burt, & Sonnenberg, 2000).
Unfortunately the number of tests which have been shown to demonstrate both of these
traits is a very small percentage of the hundreds of commercially available tests. If a test
has neither analytic nor clinical validity it is not generally recommended by the majority
of health and scientific communities.

The use of genetic testing in the clinical setting is a fairly recent development. The
process typically involves a physician ordering a test in order to confirm a diagnosis or
to determine a specific treatment. These tests are performed by different laboratories,
usually outside of a physicians practice. Each physician or hospital has purview to
decide which company he or she uses to complete genetic testing for their patients.
Typically, a physician only orders tests which have the ability to positively impact
physical health outcomes for an individual. Due to the variations in human reaction and
experience the mental health impacts (such as stress and anxiety due to a misinterpreted
test result) are even more complex than the physical implications and are outside the
scope of this work. The physician then reviews the results and implications with the
patient and then the two make decisions together based on all available clinical
information, including genetic test results.

Having a physician aid in decision making is ideal for the patient because it provides an
opportunity for someone with applicable knowledge to help the patient understand
information and make informed decisions. However, the advent of direct-to-consumer
(DTC) advertising presents a dilemma to each person considering genetic testing. Due
to its much longer history, DTC advertising is most often discussed in the context of
6

prescription drugs. However there has been a recent and dramatic increase in the
number of genetic testing laboratories using this method to attract customers. There are
many protections from DTC advertising of prescription drugs by numerous agencies of
the federal government. These protections limit how companies can represent and
market their products. However, the federal government has not implemented similar
regulations on genetic testing advertisements. In addition, the potential consumer of a
prescription drug is protected by the fact that a physician can act as a gatekeeper because
a doctor is still required to write a prescription for a particular medication. In many
states patients can order genetic tests directly from companies and receive results
without any physician or genetic counseling guidance. Economic theory suggests that
the lack of a gatekeeper results in an incentive for firms to create supplier induced
demand. This would create an overproduction of genetic test (Folland, Goodman, &
Stano, 2007). Firms can accomplish this through aggressive marketing and advertising
and this is arguably what we see in the current genetic testing market.

The Centers for Medicare and Medicaid Services (CMS) the Food and Drug
Administration (FDA) and the Federal Trade Commission (FTC) are the oversight
bodies for laboratory developed tests (LDT’s) such as genetic testing. The Clinical
Laboratory Improvement Act (CLIA) is the law which grants CMS the ability to conduct
periodic “proficiency testing.” This act was designed to “strengthen federal oversight of
clinical laboratories to assure that the tests results are accurate and reliable.” It was
based on congressional hearings which determined that lab tests had a large impact on
clinical outcomes (Javitt, Stanley, & Hudson, 2004).

A significant gap in this act is that it lacks specificity as to which tests to regulate and
how to regulate them. It also contains no provisions regarding the advertisement of any
medical device or procedure, including genetic testing. Over time the FTC and the FDA
have stated that they have joint purview over the advertising of LDT’s. However,
neither has taken the initiative to regulate the advertising of genetic tests. Both have
cited limited resources as the reason why genetic testing advertisements are not
regulated similarly to prescription drugs (Gollust, Hull, & Wilfond, 2002). The only
action taken by the FTC to date is a warning statement issued in 2006 that consumers
7

should be wary of claims made by testing companies and should enlist the help of a
qualified physician in deciding whether to order genetic tests and interpreting the results.
The FDA has only begun to take action and has started to warn companies and held open
forums relating their concerns and allowing for input from parties with vested interests
regarding advertising practices (Pollack, FDA Faults Companies on Unapproved
Genetic Tests, 2010).

Although not cited by the government agencies as a barrier to regulation, it is also the
case that the link between genetic testing and poor health outcomes is difficult to
establish. The connection between prescription drugs and negative health outcomes has
been more easily identified, placing more pressure on the government to regulate those
ads. In the case of genetic testing there are several logical steps between the
advertisement and the health outcome. First, the patient must decide to take the test, the
patient must then interpret the test results, and then the patient must make a decision
whether or not to consult others regarding the test results. Finally the patient must make
a decision regarding his or her health. That decision will have an impact on the patient’s
health and may be positive or negative or neutral depending on a multitude of factors.
Figure 1 demonstrates these steps graphically. They can choose to include or disregard
the genetic information in that decision. As a final note, the patient must also decide
whether to tell his or her biological family about the test results, which may have
implications for their health as well. These complex steps make the justification more
complex and thus remove pressure on the federal government to establish regulations.
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Patient Decides
to Order Test

Yes
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on Interpretation
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Incorrectly

Correctly
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Impact

Patient Interprets
Information with
Professional
Guidance

Negative health
Impact

Figure 1. Flowchart of patient decision making steps which may involve a genetic test.

The lack of federal oversight has forced individual states to legislate and enforce
individual regulations. This has left the country with a patchwork of laws with varying
strictness. Some states have remained entirely silent on the issue. Others require that
patients meet with physicians for any genetic testing which has clinical applications.
Still other states have completely banned any DTC advertising and only physicians may
order these tests. Because the internet is such a widely utilized resource, both for
companies and persons seeking genetic tests, it is difficult to determine who is being
impacted by a given advertisement. It is entirely plausible that a patient in one state
with strict regulations will visit the site of a company in a state with no regulations and
obtain genetic testing without a physician’s guidance, rendering the state law moot.
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A typical scenario where the lack of regulation would negatively impact health
outcomes might play out as follows. A woman with a family history of breast cancer is
interested in seeing if she has an increased risk for cancer. She searches the internet for
genetic testing sites and although she lives in New York, a state which strictly prohibits
DTC advertising she is able to access 23 and Me’s website. The company’s
advertisement states “BRCA1 and BRCA2 mutations account for most (though not all)
cases of inherited breast cancer in women (23 and Me, 2011).” Relieved that there is a
test which can assuage her fears she purchases the test. She is mailed a test kit and
sends her sample back to the laboratory. In a week she receives the results, she is
negative for both BRCA-1 and BRCA-2, meaning that she is not at increased risk for
hereditary breast cancer. Because she has not spoken with a physician she takes this to
mean that she will not get breast cancer. However, while this result does decrease her
risk of hereditary breast cancer it does not account for the large percentage of cases
which are not hereditary. In fact, having either BRCA-1 or BRCA-2 increases the
lifetime risk of a woman developing breast cancer from 12% to only 60% (National
Cancer Institute, 2005). The woman in this scenario still has a 12% lifetime risk of
developing breast cancer. 23 and Me does present information to this effect on the page
but it is unclear whether consumers are able to draw the complex connection. If she
misunderstands it, this information reduces the likelihood that she will engage in
preventative behavior (mammograms and self-exams). Five years later she notices a
lump. By the time her cancer is diagnosed it has metastasized throughout her body and
in addition to the personal costs and pain associated with therapy her medical costs
skyrocket. This anecdote provides one example of how the misinterpretation of a test
result could lead to poor health outcomes for the patient.

This scenario illustrates how poor information and the lack of regulation could have a
devastating impact on a patient. Although the company’s website was technically
accurate, it did not provide all the information the patient needed to make an informed
decision about her healthcare. Because the regulations were different in each state, the
state law which was supposed protect her was rendered useless by the interstate nature
of the internet. A federal regulation or interstate pact may be required to protect the
health of both individuals and the population. Regulating this type of advertising on a
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national level would help to prevent this and similar issues from occurring due to
inconsistencies in regulation.

There is a precedent for national regulation in light of inconsistent state laws regarding a
medical topic. The issue of abortion has remained contentious for decades but prior to
the 1973 ruling of the Supreme Court in Roe v. Wade individual states had differing
regulations on whether women were allowed to get abortions. The result of this was that
women in states with restrictive abortion laws were forced to either travel to a state with
fewer restrictions or to obtain the abortion illegally. This decision could result in
significant pain, sterilization, and even death. By setting a national standard, the
Supreme Court was able to make a medical procedure available to all women regardless
of which state they resided in (Pence, 2011). The case with DTC genetic testing is
similar in that requiring individuals to consult a physician would be equivalent to
providing individuals with access to a service consistently on a national level.

While a link has been established between poor analytic validity and poor health
outcomes, the link between incomplete or misleading advertising is less proven. Beyond
that, no one has examined whether the advertisements themselves are misleading to
consumers. There have been a few studies which have established that advertisements
may contain incorrect information, but no one has determined whether patients can
understand information presented accurately in advertisement, or whether the misleading
advertisements have an effect on actual patient decisions. Anecdotal evidence suggests
that this may be the case but there have been no systematic studies of how consumers
process the highly technical information presented in genetic testing DTC
advertisements (McBride, Wade, & Kaphingst, 2010).

A New York Times article examined the extent to which direct to consumer genetic
testing was occurring in March of 2010. The industry’s leader, 23 and Me was noted to
have tested 35,000 customers. Two other companies, Navigenics and Decode Genetics
have provided services to 20,000 and 10,000 customers respectively. The article itself
argues that the market is relatively small. However, the numbers tell a different story.
According to a filing with the Securities and Exchange Commission in December 2009
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23 and Me raised $27.8M. This indicates that the size of this problem is not
insignificant and while these companies may begin to struggle (as the article contends),
this could cause them to utilize even more aggressive advertising, further inflating the
demand and potentially causing more harm to misled consumers (Pollack, Consumers
Slow to Embrace the Age of Genetics, 2010).

Another news article in the Washington Post compared DTC genetic test marketing to
the way Apple aggressively marketed the iPod and how other high tech companies
market their products (Cruikshank, 2010). What this article fails to note is the health
impact from a genetic test is still unproven and it is unclear whether aggressive
marketing practices are appropriate for products which have a primarily medical
purpose. There are also questions regarding whether consumers can comprehend
material presented in these types of advertisements. While both examples demonstrate
the power of consumerism, when the products being marketed may have impacts on
health it is even more important for consumers to understand what they are buying.

Within the past several years genetic testing has become more publicized in media
outlets. Highlighting this increase in attention is a series of articles by Greg Pollack in
the New York Times (of which the articles noted previously are a part) which has
followed the issue closely (Pollack, FDA Faults Companies on Unapproved Genetic
Tests, 2010). As this issue gains more attention it is likely that more people will be
interested in obtaining these tests, whether or not they have clinical value. Pollack’s
articles focus on government action against DTC companies and one could argue that
they are a call for action. As a result of the increased public attention and other factors
in 2010 there was a dramatic increase in action by the FDA on looking into DTC genetic
tests (Singer, 2010). However, no finalized regulations have been established and there
is a call for more research to be done examining what the potential impacts of this
technology could be and whether it should be regulated. One aspect of this research is
examining how consumers process and comprehend the information presented in DTC
genetic test marketing.
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BACKGROUND AND LITERATURE
There are still significant questions as to whether these tests and their advertisement
should be regulated, yet few studies have examined the impact of advertisements on
clinical outcomes. There are many editorial and opinion pieces published regarding this
issue, but there is little research to support them. The studies that have been conducted
focus primarily on the actual validity of the genetic tests. Research focused on the
advertisements themselves use expert opinions of the factual information in the
advertisements but do not account for the general public’s perception of the issue.

The DTC advertising of prescription drugs is closely related to that of genetic testing.
Prescription medication advertisements are strictly regulated therefore more research has
been done regarding the impact of DTC advertising of prescription drugs than genetic
tests. One study found that ads for prescription drugs are insufficient for consumers to
make informed decisions (Kanfar, Louden, & Sircar-Ramsewak, 2007). This research
can be applied to genetic testing advertisements as well. Because of the complexities
involved with genetic testing and the lack of regulations, the confusion is likely to be
even greater with consumers of genetic tests.

Many companies have defended their DTC policies by stating that consumers are not
utilizing the information for clinical reasons. This theory was shown to be questionable
by a study which determined that 78% of consumers who would have a genetic test
would seek their physicians help in interpreting the results (Caufield, Ries, Ray,
Shuman, & Wilson, 2009). This indicates that the primary reason for patients to
purchase genetic testing is that they believe knowing their genetic structure will have
some positive impact on their health and their lives. Whether or not this belief is an
accurate one is something that is still not proven.

An article published in the Journal of the American Medical Association (JAMA)
examined several advertisements for their accurate portrayal of a test and whether the
tests themselves had both clinical and analytic validity. Their research found that each
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of the advertisements had at least one of three problematic aspects. The first is that the
advertisements themselves were misleading. The second is that the information being
advertised is complex, a fact which cannot be accurately portrayed in the abbreviated
communications. Lastly there is a large amount of contention over whether the tests
being advertised have substantial clinical utility (Gollust, Hull, & Wilfond, 2002).

In order to determine the clinical validity of genetic tests for cancer Marchionni et al.
examined three separate tests. They found that the three varied in their ability to both
accurately analyze the genetic information and provide valuable clinical data. Of the
tests studied, Oncotype Dx, had the best clinical utility, but even its clinical utility was
insufficient to be considered definitive. Further, the authors determined that more
population genomic research was required in order to prove clinical utility (Marchionni
& Marinopoulos, 2008). Although this was not mentioned in the article, all three tests
were available to the public and were advertised as pharmaco-genetic indicators.

A report from the conservative bioethical think tank, The Hastings Center, identified one
print advertisement for BRCA-1 and BRCA-2 genes and systematically reviewed it for
its merits and problems. They determined that the ad overstated the test’s ability to
predict and misrepresented what the test actually did. This determination was made by a
group of experts in the field (Hull & Prasad, 2001). While this study does present
valuable information, it only establishes a problem for one advertisement and does not
consider how the public itself would view the advertisement. The authors assume that
because the public has a limited knowledge of the tests that they would be misled.
There has been no research to date regarding whether this assumption is accurate.

In a study published late in 2010, Rahm reviewed the findings of a focus group of Kaiser
Permanente Health Plan members regarding their thoughts on genetic testing. The
group considered both genetic information presented in advertisements and test results.
The conclusion of the author was that there was a large amount of individual variation
with regards to opinions on genetic testing and potential impacts of test results on
individual decision making. This study demonstrates that there are many factors which
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may influence how patients comprehend and process information presented in these
advertisements (Rahm, 2010).
Another study by McBride et al. examined the impact of genetic test results on
consumer decision making. The authors note that there has been no established research
demonstrating harm to patients as a result of receiving DTC genetic tests. The authors
recommend accelerated research including long-term responses to information, optimal
support decision making and looking at primary care provider competency as it relates
to genetic testing. The implications of this paper are that it solidifies the need for future
research on this topic and the social impacts of DTC genetic tests, specifically the link
between DTC genetic tests and clinical outcomes needs to be established (McBride,
Wade, & Kaphingst, 2010).

In addition to these studies, several editorials and opinion pieces have theorized that the
general public does not have the knowledge necessary to make informed decisions
without the help of a physician. A statement from the Genetics and Public Policy center
claims that, “consumers are vulnerable to being misled by advertisements and lack the
knowledge to make appropriate decisions about whether to get tested or how to interpret
the results (Williams, 2008).” This and similar theories have not been examined
systematically and we are uncertain whether the public does have the understanding
required to properly interpret the test results.

Along with the peer-reviewed literature, and in conjunction with the public interest in
this topic, there have been two hearings held before various House of Representative
subcommittees by the Government Accounting Office (GAO). In 2006 the GAO
testified that advertisement claims were often vague and at times blatantly false and that
they contributed little to patient health awareness (Government Accounting Office,
2006). More recently the GAO presented a report which stated that the tests themselves
are misleading and that they are being marketed inappropriately to consumers. The
GAO sent DNA samples to five different companies and often received conflicting
information from those companies as to genetic risks (Government Accounting Office,
2010).
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METHODOLOGY
In order to assess how consumers understand these advertisements a survey was utilized
which measured their scientific background, comprehension of the information
presented and key demographic questions. A survey was selected as the research
instrument in order to gather a wide range of information on a relatively large cohort at a
specific moment in time.

The instrument can be found in Appendix A and contains questions in three sections:
demographics, interpretation of the advertisement, and scientific background. The
participants were presented with information from 23 and Me’s website regarding their
genetic tests for alcohol dependency and were asked a number of questions on the
material presented. Questions included multiple choice, “Yes / No” free text and likert
responses.
COHORT
The faculty and staff at the Rochester Institute of Technology (RIT) were chosen as a
cohort for several reasons. There is likely to be a mix of education both in terms of
highest level achieved as well as field of study. Students were not included because of
their limited age range and a decreased likelihood of purchasing the test in the near
future. Including a wider range of ages may provide information regarding differences
in age groups and comprehension. This cohort was also selected because they are more
likely to be interested in obtaining the genetic tests and more likely to have the means to
purchase the tests. Lastly, they represent a convenience sample due to time and resource
constraints.

There are potential limitations associated with this cohort. There is likely to be a bias
toward persons with a high amount of technical skill because of the nature of the
university being sampled. With a history steeped in technology and a faculty and
curriculum that support technological education there is significant cultural importance
placed on that subject. The result of this is that it is likely that individuals who have an
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interest in technology and science are likely to be drawn to this university. In addition,
because the survey was distributed by email, the sample is limited to faculty or staff with
an RIT email account, potentially excluding less educated members as they would be
less likely to have an email address that is checked frequently. There may also be a selfselection bias as persons who have a background in biological or medical sciences may
be more apt to respond to the survey. As a result of these biases the results may not be
able to be generalized to the U.S. population. However, if this cohort still demonstrates
a lack of understanding of the advertisements, it is unlikely that the general public will
be able to interpret them.
INSTRUMENT
The RIT Institutional Review Board (IRB) input and approval were obtained during
survey development and prior to distribution. The survey was distributed to faculty and
staff at RIT via an email containing a link to an RIT clipboard survey and a brief
description of the research and its intent. Distributing the survey in this manner created
a straightforward way for participants to respond and ensured that the majority of the
faculty and staff receive the email. The limitations of this method are that it limits
persons without consistent email access from participating and therefore may skew the
results towards faculty and away from staff. Additionally, a survey limits the ability for
follow up discussion based on participant responses.
Participants were presented with a screenshot taken from 23 and Me’s website.
Specifically the entire webpage on alcohol dependency was presented unaltered as it was
available in February of 2011. They were asked to take several minutes to review the
screenshot and familiarize themselves with the information. There was no time limit
placed on the review period since respondents were able to return to the material during
the survey (although this was not suggested or mentioned in the instructions). The
respondents were asked to begin answering questions once they felt comfortable with
the material.

This company was selected because it is currently the largest distributor of DTC genetic
tests in the U.S (Pollack, Consumers Slow to Embrace the Age of Genetics, 2010).
17

Alcohol dependence was selected to be the condition and test because it is not gender
dependent, is relatively well-known by the public, and has both genetic and
environmental factors which contribute to its clinical presentation. 23 and Me identifies
their test as a “disease risk” test and also as a “preliminary research report.” The number
of tests noted as preliminary is 72%. The majority of tests are also classified as “disease
risk” (23 and Me, 2011). Therefore alcohol dependency is representative of the majority
of tests made available by this company

The first section of the instrument asked for demographic information from the
respondent. Because genetic tests vary in reliability depending on ethnicity and sex it
was important to have the participants self-identify both of those factors. In addition,
participants were asked to identify their level of education and area of study (if
applicable) as well as their current occupational field. Both of these measures were
collected as potentially important predictors of comprehension.

The second section of questions attempted to establish what participants were able to
glean from the information presented to them. They were asked to respond to several
questions on both the content of the advertisements and what their impressions of the
test itself are, as well as whether they might take action based on the results of the test.
Questions included “Yes/No”, free text, Likert scales and multiple choice. The type of
answer was dependent on the question being asked and whether the potential answers
could be easily categorized. In some instances it was important to allow participants the
ability to react in depth to the question. For other questions, scales and categorized
answers allowed for easier analysis and created a homogenous data set.

Lastly, respondents were asked several questions to measure the depth their scientific
background and literacy. These questions were primarily an effort to establish whether
the assumption that persons at RIT may be more technically savvy is correct. These
questions also helped to identify possible correlations between scientific understanding
and advertisement comprehension. Without better understanding how participants
understand the background material it would be impossible to interpret their responses to
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the comprehension questions. For a listing of all questions and the purpose behind each
particular question please see Table 1.

TABLE 1. A list of each question and reasoning behind why it was asked. When applicable, the reason
for the question being asked in a particular way is noted
ANTICIPATED
QUESTION
PURPOSE
RESPONSE
1) What is your age?
Identifies age-rage of sample
Varied, but with a
for normalization purposes
distribution centering
Helps control for the topic, as
around between the ages
alcohol is pervasive on college
of 30 and 50
campuses
2) What is your sex?
Identifies sex of sample for
50% male and 50%
normalization purposes
female
 Male
 Female
 Other
3) Education (please select one)
Identifies education of sample
The majority of
to compare to U.S. population
individuals will have a at
 Some High-school
Provides insight into whether a
least a bachelor’s degree,
 Graduated High-school
correlation
may
exist
between
 Attended some college
education level and knowledge
 Associate’s degree
of topic
 Bachelor’s degree
4) If you have received a college
Further clarifies question 3 for
A high percentage of
education (associate’s or more) please
analysis
liberal arts, science and
indicate your major
engineering respondents
5) What is your highest terminal degree? Further clarifies question 3 and
Many advanced degrees
4 for analysis
6) What is your current occupation?
Administrators / Faculty
7) Ethnicity
The genetic test presented only
A large percentage of
applies to a certain ethnicity,
Caucasians
 African America
ethnic background of sample
 Asian / Pacific Islander
may have impacted responses
 Caucasian
 Latin / South American
 Native American
 Other
8) What are your impressions of alcohol
Asked before analysis questions Varied by individual
dependency and genetics?
to attempt to obtain a baseline
of participants’ understanding
of topic
9) How many studies are described in
Attempt to determine whether
3
this advertisement?
the structure of the website
information was clear
10) If you had a family member who had This question was developed to Varied by individual
a dependency on alcohol would you be
determine the participants
interested in getting a genetic test for
interest level in alcohol
yourself?
dependency
 Yes
 No
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11) If you had a blood relative who had a
dependency on alcohol would you be
interested in getting a genetic test for
yourself?
 Yes
 No
12) What is the relationship between
marker RS27072 and alcohol
dependency?
13) How closely are genes and alcohol
dependency related (Likert)?
 Not closely At All
 Not Very Closely
 Somewhat Closely
 Fairly Closely
 Very Closely
14) Does ethnicity have an impact on
this relationship?
 Yes
 No
15) If so, how?

Attempt at determining whether
participants would vary their
response based on a hereditary
vs. familial proximity to the
topic

Varied by individual

Attempt to determine whether
the content of the website
information was clear
What were the participants’
overall impressions of the
website and how closely the
genetics and alcohol
dependency were related? A
likert scale was utilized to
simplify for coding purposes

Having a particular allele
lowers the odds of having
withdrawal seizures
Varied by individual

Did the participants notice the
ethnicity qualifier present on
the website?

Yes

Clarifying question 14. If the
participant guessed correctly, A
free text response allows them
to explain their response

16) How interested are you in this
condition (Likert)?
 Very Uninterested
 Not Interested
 Neutral
 Somewhat Interested
 Very Interested
17) Approximately how many people’s
genetics were studied to determine the
relationship between marker
RS18001197 and alcohol dependency?
 10
 100
 1000
 10000
18) What would you do if you received a
test result that indicated you had this
gene?
 Nothing
 Seek more information on the
condition on the internet
 Talk to my doctor about the
risks
 Call the company to speak to a
genetic counselor

An attempt to control for formal
education. If someone was very
interested in the topic they may
be more educated than would
be typical

Studies only included
European and Asian
ancestries, results may
not apply to other
ethnicities
Varied by individual

Attempt to determine whether
the content of the website
information was clear

10,000

A look forward at what the
potential “end-user” acceptance
of the policy would be if they
were required to utilize a
physician as a gatekeeper

Varied by individual
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19) Where did you receive the majority
of the information?
 Charts
 Graphs
 Numbers
 Text
 Photos
20) What is an established research
report?

21) What journals did the research stem
from?

22) What is a SNP?

23) Susie requested that this analysis be
done for her. The result stated that she
had an increased risk for alcohol
dependency. The letter from the lab said
that her test was ____.
 Positive
 Negative

This question was aimed at
obtaining which piece of the
website the participants found
most helpful.

Varied by individual

An attempt at determining what
the general consensus was
regarding this language as it is
not defined by any traditional
convention, yet is used by 23
and Me.
This question’s intent was to
determine whether individuals
could determine the journal
names based on their
abbreviations
Because this acronym is used in
the website but not defined, this
was asked to determine what
the general knowledge of the
term was
Because there are differences
between the social and clinical
connotations of positive and
negative, this was asked to see
whether participants could
separate those meanings.

There is no official
scientific definition for
this term

Archives of General
Psychiatry, Molecular
Psychiatry, and
Alcoholism: Clinical &
Experimental Research
Single Nucleotide
Polymorphism

Positive

ANALYSIS
The analysis of the survey results included both basic statistical and interpretative
qualitative analyses. Interpretive analysis was used on any answers which were
provided via free text. In order to obtain the most information from this limited sample
it was important to use qualitative methods such as interpretive analyses to better
understand the respondent’s mindset. By using basic statistical analyses to establish
areas of interest and furthering that work with interpretive analyses I was able to develop
an adequate picture of whether this sample of consumers understand the advertisements
and whether the ads have a potential impact on their future decision making if they were
to obtain the test.

Free text was analyzed with either interpretive analysis or a coding scheme, depending
on the information. Therefore the coding scheme was developed after data based on the
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data which was obtained. Using this scheme, themes were developed and categorized to
both help describe the sample and identify trends.

Simple statistical analyses looking at correlations between all the variables were
developed in order to examine if any relationships may exist. The relationship between
education and comprehension were examined (as measured through several questions)
were as well as between ethnicity, age and gender and potential decision making. The
apparent gaps in understanding were especially important to review, given sample’s
scientific background.
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RESULTS
103 responses to the survey were received. All responses were included in the analysis.
While it was clear that some persons were unable to see the actual advertisement it was
decided that their response to the questions was as valuable as the ones who did not
complete the survey. There was an issue with one particular browser type and the ability
to view the screen shot. The responses they provided to the scientific background and
demographic questions should not have been impacted by the advertisement. Further we
can assume that they chose not to answer questions pertaining to the advertisement when
they could not see it. Therefore no response was eliminated from the analysis. Where
noted there were questions left unanswered by certain respondents.

Demographically the sample was relatively diverse. 54% of the respondents were
female and 46% were male. The average age was 47.8 years, with a standard deviation
of 15 years indicating that 68% of the respondents were between the ages of 32 and 62.
Of those that responded to the question “What is your highest terminal degree,” 68%
noted that they had achieved a master’s degree or higher (n = 60/88). Fields of
education were relatively diverse as well with the majority being liberal arts disciplines
as well as a significant number being business, science and engineering (See Table 1).
Ethnically the vast majority (92%) identified as Caucasian.

TABLE 2. Break-out of demographics by discipline. Note that there is a wide distribution of disciplines
identified by the respondents.

Discipline
Engineering / Computer Science
Liberal Arts / Fine Arts
Science
Unclear / No Answer
Total

Count
20
35
15
19
103

Percentage
19%
34%
15%
18%
100%

The next section of the survey focused on the respondent’s impressions of the material
which was presented to them. The first question allowed free form response to “What
are your impressions of alcohol dependency and genetics?” Upon coding of the
responses, 50 persons acknowledged some form of relationship, 11 stated that they
23

believed there was no relationship and 23 noted that both genetics and environment
could have an impact on alcohol dependency.

The next two questions focused on determining whether respondents distinguished
between family member and blood relatives in terms of relations. When asked if they
would be interested in getting a genetic test for themselves if a blood relative or family
member had a dependency on alcohol the majority in both cases (66% and 65%
respectively) stated that they would not be interested in the test, however 8 respondents
(8%) changed their response in some way.

When asked what the relationship between RS27072 and alcohol dependency was there
were a wide variety of responses. 24 (18%) individuals stated that they did not know or
left the answer blank. 61 (58%) respondents identified “withdrawal seizures” or
“symptoms” in their response. 18 respondents identified that there was some
relationship but only noted a general correlation to alcohol dependency.

TABLE 3. Categorization of answers to how respondents viewed the relationship between marker
RS27072 and alcohol dependency.

Total
Responses (N)
24

Percentage
(%)
23

Noted relationship but no
identification of withdrawal
seizure correlation

18

17

Noted “withdrawal seizures”
or “withdrawal symptoms”

61

59

Response Category
Did not know / Blank

When asked how closely genes and alcohol were related the majority (52%) stated
“somewhat related.” The rest of the responses appear to follow a normal distribution in
terms of their interpretation of the directness of this relationship. This is demonstrated
in Figure 2.
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Closeness of Genes and Alcohol
FIGURE 1. Results of the asking survey respondents to define the relationship between alcohol
dependency and genetics on a likert scale. Raw counts are presented here to demonstrate the normal
distribution of the responses.

Because the advertisement noted the applicable heredities for these tests, the respondents
were asked whether ethnicity had an impact on the relationship between genetics and
alcohol dependency. 49% answered that it did not, 45% answered that it did and 5
respondents did not answer. When asked to expand upon that relationship, if there was
one, respondents answered from varying perspectives. Some listed general thoughts
regarding ethnicity, others noted the ethnicities from the advertisement and still others
listed that they were unclear as to the exact nature of the relationship.

When asked how many people were studied in order to determine the relationship
between a specific marker and alcohol dependency 64% chose the correct answer of
10,000 people, while 18% chose incorrectly and 19% simply did not answer.

Respondents were asked to answer on a Likert scale how interested they were in the
condition. 43% chose the “somewhat interested” option with the others selecting
neutral, not interested very uninterested and very interested 24%, 15% 9% and 6% of the
time respectively. Two respondents did not answer. (See Figure 2).
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FIGURE 2. Graph demonstrating the level of interest in alcohol dependency noted by respondents who
answered (6 participants did not provide a response). As predicted the majority of individuals were
somewhat interested or neutral toward the topic.

When asked where they received the majority of the information the vast majority
responded ‘text’ (80%). The remaining noted that they received information from
charts, numbers and graphs in descending order.

The respondents were presented with a question which allowed multiple responses to
what their action plan would be if they received a test result indicating that they had
“this gene.” 49 respondents stated they would go to their doctor, 31 would do nothing,
21 would do further investigation on the internet and 6 would seek out a genetic
counselor provided by the company doing the testing.

The last segment of questions focused on determining what the basic scientific
knowledge of the sample was. Because the company uses the term “established research
report” in their description of the tests, persons were asked what that term meant. 21
responded with some variation of “I don’t know” or “not sure.” 23 did not answer the
question. Of those that did answer 26 stated peer review as part of the criteria of a
research report. Three individuals noted that “established research report” has no
significant meaning.
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The respondents were also asked what journals the research was published in. 34
individuals responded by copying the abbreviations listed in the advertisement, 8
respondents wrote out the full titles of the journals. Two respondents made note of the
fact that the titles were only presented in abbreviated form.
Individuals were asked what a “SNP” was. Only 12 individuals responded with accurate
answers, of these 4 noted that they used an internet source to research the information
before responding. The remaining respondents did not answer the question, stated they
didn’t know the answer or responded inaccurately.

When asked to determine whether a test result was positive or negative for a
hypothetical person, 7% of respondents responded inaccurately and 8% chose not to
answer the question.
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DISCUSSION
The survey was distributed online in order to limit the study sample to persons who
might have the opportunity to interact with the material presented in the survey. This
limitation was enforced in order to target the survey to a more representative sample of
potential utilizers of these tests. Including persons who do not use the internet would
have added limited value to the survey responses. In addition, targeting people who
have a general understanding of the internet allows the researcher to make certain
assumptions when asking questions, allowing for more specific information gathering.
For example, it was possible to assume that the respondents would be able to understand
how to navigate the survey and respond accurately to the questions. It is likely that
individuals familiar with the internet would have taken online surveys previously and
would therefore be able to navigate and answer questions with little direction in the
content of the survey. From a policy perspective, only surveying those who might
interact with the test allows us to understand the opinions of individuals who might
interact with the advertisements and tests, thereby allowing us to gauge the perception of
those who might be impacted by a regulation.

The population the study sample represented was that of RIT faculty and staff. This
population was well represented with an almost even distribution of men and women.
The majority of respondents had at least a Bachelor’s degree, indicating a higher level of
education than is typical for the U.S. citizen. In 2010 29.9% of US citizens had obtained
a minimum of a 4 year degree while 84.5% of this sample noted that they had obtained
at least that level of formal education (US Census Bureau). This significant difference
implies that the overall the individuals studied were more likely than the average U.S.
citizen to have some formal education in a scientific discipline. There was a large
proportion of respondents with careers in liberal arts, science and engineering. For those
disciplines we can assume a higher likelihood that these individuals have received some
form of formal training which would assist in their understanding of the material
presented. Therefore we can infer a relative familiarity with the material. By
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acknowledging this familiarity it is possible to make better inferences to the survey
responses that follow.

The demographics of this population were sought for several reasons. Due to the value
placed on technology at the university (Rochester Institute of Technology, 2012), the
faculty and staff at RIT are more likely to be technologically inclined and therefore
potentially more likely to encounter and subsequently purchase DTC genetic tests.
Additionally there is a higher likelihood of an above-average education level. However,
there is still a large proportion of individuals with limited educations. It may be that
those individuals are the most at risk in this environment as they have access and interest
in these services but are lacking the formal education that may be required to better
interpret both the advertisements and the tests themselves. Due to the nature of the
university there may be some pressure for these individuals to have a greater
understanding of scientific material and they may be reaching out to unqualified sources
for answers, the result of which could be a misunderstanding of the material. For these
reasons, this selection of individuals makes RIT an excellent sample set for this
research.

Because it was assumed that a typical RIT employee would have a higher education
level than the average internet user it is likely that they would have a greater chance of
understanding the information presented. By using this strategy, if the individuals with
a relatively high education level cannot understand the information then it is likely that
those with less education will struggle as much, if not more so. By selecting for more
highly educated individuals, there is an increased likelihood that the results are as or
more meaningful for persons with lower levels of education. The level of scientific
literacy is likely to be higher in those individuals studied and therefore results may be
applicable to individuals with lower levels of literacy.
The respondents’ answers to the interpretation questions were enlightening. Their
impressions of alcohol and genetics were coded in order to glean further information.
Because the majority of respondents noted that there was some sort of relationship we
can infer that, in general, this population believes that this condition is at least somewhat
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inheritable. One respondent was confident enough to respond with exact percentages.
They noted: “Variability (38-64%) of predisposition related to genetic factors (Science,
Post-Baccalaureate)” While research has shown that alcohol dependency is very directly
tied to environment (Theall, et al., 2009), only 23 respondents independently noted the
environment in their response. The more typical response was similar to “Genetics do
matter, but are not the only important factor (Liberal Arts / Fine Arts, PostBaccalaureate)” This indicates that the individuals responding were acknowledging that
something else has an impact on alcohol dependency but were unwilling to take the next
step and indicate that the environment has an impact. This could mean that when
examining the advertisement persons tend to relate only to the information presented to
them and not consider what they likely know to be true in a different context. It would
be interesting to test this hypothesis with a focus group study which provided two sets of
participants with different sets of information and determined how they limited
themselves to what was presented and / or utilized their own experience to answer
questions.

As with many types of social research, the instrument may have had an impact on
individual responses. Further exploration utilizing different instruments and
methodologies would be useful to confirm this research. Because only one test from one
company was utilized it is unclear what impact different tests and different
advertisements would have on the results. In addition, by presenting the survey online
and allowing respondents to refer back to the materials this study may be an overestimate of respondents’ actual retention and more of a review of their strict
comprehension.

This indicates that consumers may require more information than what is presented in
the results of the studies by a certain company. While the advertisement does give some
background it is general descriptions of the condition. Perhaps companies should be
required to give a more comprehensive scientific literature review in these types of
advertisements. It is clear that not all respondents have a clear and comprehensive
understanding of all of the factors which influence alcoholism.
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Alcoholism was chosen as the test profile of choice because of the numerous social
issues surrounding it. Even when compared to other substance abuse disorders, alcohol
dependency is more highly stigmatized. Persons with alcohol dependencies are more
likely to be held responsible for their addictions and provoke more negative emotions
than other chemical dependencies (Schomerusl, Lucht, Holzinger, Matschinger, Carta, &
Angermeyer, 2010). Because of its prevalence, it represents a type of disorder where
persons are likely enough to be familiar with it but unlikely to have extensive knowledge
of the topic. There are biases that result from additional knowledge of the subject. One
respondent noted that they had experience with Native Americans and as a result
believed there to be a genetic influence. While some of this previous knowledge exists
in the survey results, utilizing this particular test instead of something as familiar as
breast cancer likely limited that impact.

Although it was limited, it is important to note that racial and other biases do exist in the
population (as noted previously) and that they might be influencing decision making
regarding genetic testing. People’s inherent knowledge may be a key factor and force a
decision regardless of the information presented in an advertisement or website. Future
research should focus on identifying what portion of potential users have already
decided to utilize DTC genetic testing before doing online research.

In order to determine whether respondents identified a difference between family and
blood relatives receiving test results (and the meaning of each) two questions were asked
to that effect. While the percentage of persons responding that they would not be
interested remained similar, 8 individuals changed their response. This indicates that for
some people having a blood relative receive a positive result is different than having a
family member receive one, and that these people may place a higher value on the
genetic component.

In general respondents indicated that they thought genes and alcohol were somewhat
related. The rest of the responses fell in a normal distribution around that response.
While this indicates a broad understanding of the relationship, it is clear by responses to
following questions that the details of the relationship are not entirely clear to this
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population. Although the information was made readily available as they answered the
survey, a large number of participants were unable to articulate the relationship between
one of the genetic markers included in the test and alcoholism. As a result of this gap,
individuals may believe that they have a greater understanding than they actually do.
Due to the publicity that genetics have received over the past two decades it is possible
that individuals have a false perception of expertise when it comes to all genetic tests as
a result of being informed through lay media which, in general, is unable to convey the
full complexities of an issue.

Developing safeguards against this type of mentality may be another place for
implementation. Perhaps individuals who receive certain tests should be quizzed on the
impacts of those tests and the overall diseases and their relationships to genetics.
Informed consent is a concept which has been common to U.S. medical practice for over
50 years (Salas). Engaging patients in a program to ensure informed consent may assist
in the incorporation of correct information in to their decision making processes.

In considering informed consent, we must first examine the language utilized in
discussions between doctors and patients. The language which is used by doctors and
scientists is one with unique rules and subtleties which may not effectively communicate
the risk to potential research subjects or patients. Without even knowing it, researchers
make assumptions about the knowledge base of the research participant. Even when
materials are utilized to measure understanding, such as questionnaires the participant
may respond correctly but still not understand the impact of the risk or the full meaning
of the question. For example, if a doctor were to tell a patient that the risk from a drug
could include a blood clot and the patient answers on the quiz that blood clots are a
potential risk; the doctor has not truly assessed the participant’s understanding of the
risk. Because the doctor knows that blood clots can cause heart attacks and stroke he
assumes that the patient understands this as well, but it is possible that this may not be
the case at all. When this information is presented in an advertisement it forces the
discussion to become unidirectional and removes the ability of the patient to question
what is presented.
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With a topic such as genetics, science is continually moving forward and in some cases
even the individuals presenting information may not fully understand that information.
Therefore a question arises as to how it can be possible to inform patients of all the risks.
One example of this in the medical community is that of Viagra. Scientists at Pfizer
originally developed the drug to treat hypertension. However, during clinical trials they
discovered that the drug was much more efficient at aiding individuals with erectile
dysfunction (Boolel, Alan, & Ballard, 1996). This “side-effect” had not been considered
by the scientists until it was reported by participants and was not likely part of their
informed consent briefing. While this side-effect was not extraordinarily harmful it does
demonstrate the point that science is ever evolving and that it is unlikely that researchers
will even be able to communicate all the potential risks of a new procedure or drug
because they themselves are still trying to determine what those are. Currently, genetic
testing falls into this category, but because the link between the tests and outcomes is
less clear, it is even more likely that the individuals advertising for the test are unaware
of all of the potential implications of a positive or negative result.

While complete informed consent may be a lofty goal, the idea of ensuring equality of
information should be carried into the realm of DTC genetic testing. While the downstream implications are not well established, it is clear that when there is a potential for
negative consequences, patients need to be as well informed as is possible, both of the
scientific possibilities before the test is administered and of what the results truly mean.

The results of this study indicate that there may be a disparity of information in terms of
ensuring that consumers have the same understanding of the tests as those who market
those tests. In a perfect economy, one would expect a true equality of information
between producers and consumers; however it is clear that in this instance there is a
better understanding of the product by the producer than the consumer. It is unclear
what the final impact this disparity of information might have and future research should
focus on determining the extent of the disparity and what impacts, if any it has on
patient decision making and subsequent outcomes.
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49% of respondents indicated that ethnicity had no impact on the relationship between
genetics and alcohol dependency. Given that the studies were ethnicity dependent and
that this was noted in the advertisement this response is somewhat startling. The
number of people who did not either understand or missed this notation may indicate
that it is not presented clearly in the advertisement. While some individuals may take the
time to look at the studies referenced by the advertisement it may be unlikely that most
would take the time to do so. If an individual trusts an advertisement citing scientific
literature to be accurate and does not understand the true meaning of the literature itself
it is likely that they will not understand whether the information applies to them. If this
mistake is not corrected, the individual may purchase a test which is of no value to them,
or worse, they could apply misleading test results to themselves and make decisions
based on false information.

There was also confusion when respondents were asked how many people were studied
to identify a relationship presented in the advertisement. While 64% did choose the
right answer, more than one-third chose incorrectly or did not answer the question at all.
Again this may be a result of the information not being presented clearly or persons not
being able to interpret it in the way it was intended. Statistically, study size has a large
impact on the conclusions that can be drawn from a given research project. The inability
of consumers to identify this critical component of the projects is concerning. Further,
the results of this study may indicate that the underlying concept of statistical
significance is not apparent to this population. Future studies should examine the ability
of consumers to both understand why study size is important and whether they are able
to readily identify the size of a particular research sample.

These two results indicate that there may be a base set of information that needs to be
presented in every one of these advertisements which creates a common understanding
of certain terms. Ethnicity is referred to in the advertisement but nowhere is it directly
stated which ethnicities were studied to get these results. The same is true of the sample
sizes. While the ad presents the number of people in text and as a diagram it is clear that
a significant portion of this population was unable to glean this information. It may be
beneficial to design and implement a set of conventions for genetic testing advertisement
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similar to that of the conventions the pharmaceutical industry must follow when
advertising to the general public (US Food and Drug Administration, 2011).

Whether or not there was significant interest in the condition may have had an impact on
the results. Excessive interest may lead to a group of individuals with extensive
knowledge of the disease and its genetic relationships. Conversely, a bias toward
individuals with a lack of interest may indicate a lack of understanding which may result
in no knowledge of the disease. Both of these situations are less than desirable if we are
attempting to use this population as an analog to the target consumers of these tests.
When asked to identify their interest on a likert scale the majority noted “somewhat
interested” with a normal distribution of responses on either side. Therefore it appears
that a moderate amount of interest existed in this population. This is what would be
expected and therefore helps to normalize this population. There is likely no skewing of
the data as a result of excessive or no interest in the condition.
In order to see what respondents’ actions might be if they did receive a positive result
for this test they were asked what their next step would be. The majority indicated that
they would talk to their physician. As noted previously, physicians act as gatekeepers in
many instances and serve as a guide for most individuals as they navigate health care.
Having an informed and independent party available throughout a process has been
demonstrated to have better outcomes. From a policy perspective this is important
because it identifies that most people want a physician involved in this discussion and
therefore mandating that option or a similar one may be palatable to a majority of
people.

A secondary individual responsible for assisting in decision making is often made
available in the form of a health care advocate. These advocates can assist patients in
making complex clinical decisions as well as aiding in navigating the complex insurance
and legal issues inherent in the U.S. healthcare system. In times of emotional distress
and when the individual is incapable of making decisions, oftentimes an advocate will
speak to the person’s wishes, as related from previous decisions when there is no
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immediate threat. Typically the individual has clinical training and a good working
knowledge of the healthcare system. Although debated, nurses have taken on this role
and have been used in a structured model as patient advocates (Hewitt, 2002).

While not entirely applicable, this model may contain certain concepts which would be
applicable in the DTC testing arena. For example, it may be preferable to require
individuals have a consult with a specially trained social worker or other third party
before making any decision based on genetic test results, similar to the idea of a patient
advocate. With the advent of genetic testing for clinical purposes a new profession has
been developed to act in this role. Genetic counselors now exist and are well organized
as a profession with a national professional society (National Society of Genetic
Counselors, 2012). Perhaps these professionals should be made available at no cost to
the consumer to be utilized as independent resources for persons who decide to purchase
DTC testing. Patients could be notified by DTC genetic testing companies before or
after purchasing to ensure that those who are interested in genetic tests have an
additional source of information and a bidirectional information flow not provided by
the advertisements.
23 and Me utilizes a term “established research report.” After numerous search attempts
on their website it was unclear how they defined this. In order to determine how other
might interpret this statement, respondents were asked what they thought it meant.
There was wide variability in the answers but a major theme in responses was that
established reports were peer reviewed. Most answers were similar to that of one
respondent who stated, “A work of scientific research that has been subjected to peerreview within a discipline (Engineering / Computer Science, Post-Baccalaureate.)”

Interestingly, three individuals noted that there was no real significant meaning to this
title. One respondent noted “I am not familiar with this terminology. And, I must say, I
have been in the business of scientific research for a long time; but I don't attach any
particular significance to the modifier ‘established’ in this context. (Engineering /
Computer Science, Post-Baccalaureate.)” Indeed, an internet search for the term
“established research report” returns first 23 and Me’s website and no definitions of the
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term from any organization outside of 23 and Me. Again it is clear that certain terms
need to be defined as industry standards in order to ensure that all parties have an equal
understanding of the information.

When asked what journals contained the studies reported in the majority of persons
simply copied the abbreviations verbatim from the advertisement. A few made attempts
at guessing the abbreviations and some even attributed their response to an internet
search. One respondent even noted that “Would’ve b[e]en n[i]ce if they had included
the full titles of each (Unknown, Baccalaureate).” Given this, it is unclear how reliable
internet sources utilized by these individuals will be. While the persons who noted an
internet search did answer correctly this may not be true in all cases. Having individuals
rely on third parties to get their information is not a reliable and consistent way to
provide that information. In addition, it is unclear how individuals would be able to
access the primary literature on the subject and whether the abbreviations presented
were clear enough to help users find the journals.
Only 12 individuals correctly identified a “SNP.” Of those 12, 4 noted using an internet
search. One individual went so far as to say: “According to the web definition, it is a
Single Nucleotide Polymorphism; I don't know the science behind it but it is a DNA
sequence variation that was used in the cited studies (Liberal Arts / Fine Arts, Post
Baccalaureate).” This individual admits to not understanding the science but was able to
provide an adequate definition of the term. This ability to recite definitions with no
substance behind the understanding of those definitions is indicative of a lack of true
understanding of the material. Further research should be completed in order to
determine whether individuals who fall into this category of understanding actually
believe that their knowledge is sufficient to make decisions.

Because the term SNP is used in the advertisement it would be prudent for consumers to
understand the meaning of that term, however it is clear that the vast majority of this
sample did not know that answer. It is standard convention to define acronyms
whenever they are used in literature. It seems clear that given the importance of this
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information it would be important to define acronyms such as SNP in a clear and readily
identifiable manner.

7% of respondents failed to understand the fundamental difference between a positive
and negative test result. This is a concern not just in this arena but also for medical
reports in general. It also indicates that persons need results explained by someone who
is able to ably communicate the meaning of test results. From a policy perspective this
reinforces the idea that people may need a health professional to help them navigate
these results. As a gatekeeper a physician may be able to help explain these results in an
individual way which makes sure that every person understands what their result means
specifically to them. If it is impractical for a physician with sufficient training and
education regarding genetic testing to serve this purpose, it may be beneficial to utilize
genetic counselor’s to provide these services to patients.
Being “positive” and “negative” have different connotations in medical language and
popular culture. In medicine being ‘positive’ means that a patient has a certain factor,
trait, or pathogen. It is not necessarily a good or beneficial trait. Perhaps the best
example of this would be in reference to HIV. Being HIV positive indicates that you
have live virus particles in your body. This is, contrary to popular consensus, not a
‘positive’ or good state. The ‘positive’ test result counter-intuitively identifies a
negative state. Over time the confusion regarding positive and negative in context has
lessened but as we can see with genetic testing there may still be a significant portion of
the population that confuses the popular understanding of ‘positive’ with the medical
definition.

Overall, the results of this study indicate that there is a lack of understanding of the
material presented in this manner. Attributing a cause for this is difficult but given that
several authors have published concerns regarding this practice and the fact that the
majority of respondents were well educated in related fields it is likely that there is a
disconnect between what information is presented how it is interpreted. The result of
this disconnect is a dangerous situation wherein individuals firmly believe they
understand what a result means but are mistaken. This may lead them down a path of
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unnecessary treatment and difficulties which may be preventable with better
information.

From a policy standpoint it appears that individuals would support requiring a physician
or other qualified professional to interpret results with a patient. In addition it may be
necessary to regulate these advertisements in the same way prescription drug
advertisements are regulated. While there are concerns that the actual information is
useful, perhaps a less invasive approach would be to make sure that the information is
comprehendible by a wide majority of consumers and require an unbiased professional
be available for interpretation questions. This could be accomplished through a
regulatory commission setting standards on what and how items can be presented or an
independent third party assigned to review information with patients who receive these
tests.

Precedent has been set for regulation in the pharmaceutical industry. Companies are
required to give information regarding side-effects to consumers in their advertisements.
One could argue that mental anguish can cause significant health issues on par with the
numerous side effects that pharmaceutical companies are required to list (i.e. high blood
pressure). While there is limited literature linking genetic tests to negative physical
impact there is currently evidence and debate regarding this issue for a similar screening
and non-invasive test.

Currently, a debate exists regarding prostate cancer screening utilizing prostate specific
antigen (PSA) and the potential mental anguish it causes. Once a high PSA is found in a
man he often proceeds to biopsies and further treatment, even when that treatment may
not be considered beneficial. For ‘peace of mind’ many men elect to have surgery or
radiation therapy when it may be in his best interest to not actively treat the cancer
(Denenberg, Melhado, & Steiner, 2006). Genetic tests may lead to similar thinking.
There have been instances where women have elected to have bi-lateral mastectomies
when no cancer has been found but a genetic test has indicated that they are at a higher
risk for breast cancer (Smith & Issacs, 2011). The test is not 100% predictive; therefore
the elective mastectomies may be for naught. There are obviously dangers associated
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with any surgery and choosing elective surgery without proper indication has the risk of
leading to negative outcomes for the patient. Merely the risk of having a future
potential health impact can lead some individuals to take unwarranted action. By
ensuring that patients understand their genetic information completely it may be possible
to limit some of these unnecessary and costly medical procedures. Because of the
complexity of this information and the indirect quality of the side-effects it may be
beneficial to have an independent third party review this issue with patients and help
them decide whether or not to be tested for each trait they wish to test for.

While studies showing direct links between testing and poorer health outcomes are rare
because of the multiple steps involved, the logical steps are clear. This research
demonstrates and a clear disconnect between this population’s understanding of genetics
and clinical information. Further research needs to be done in order to verify and
expand these results to other populations but this preliminary research suggests that
there is clearly disconnect between what is presented and what consumers perceive.

Due to the personal nature of the subject, the medical implications and the continuing
expansion of genetic knowledge the question of regulating people’s genetics is a
sensitive issue. That considered, there are various instances of local and national
governments intervening on behalf of consumers, especially when health and welfare of
individuals is involved. The primary example of this is the food and drug
administration, which at a federal level protects consumers from false claims and
misleading advertising from medical equipment and pharmaceutical companies (Food
and Drug Administration, 2011). The findings presented here certainly support some
type of intervention. It is clear that while consumers may believe they understand these
complex relationships, a large percentage do not.

Because these tests are still primarily in their infancy, their usability in a clinical setting
is unclear. We need to be certain that consumers understand the information presented.
If someone chooses to obtain this information at a fair price then they deserve to fully
understand it. The fact that this issue applies in a market where a person’s health is at
stake also raises several moral questions beyond this basic economic tenant. While not
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addressed here, this should also be a consideration for government intervention. In
cases where the market has failed to provide equality of information it is the
government’s role to ensure that all parties understand the transaction they are about to
make. This study indicates that this relationship may exist and while further research
needs to be completed it appears that there may be a need for intervention. Because the
tests may have direct impacts on an individual’s health the need is more immediate.

There are several limitations to this study which should be improved upon in further
research. Because of the nature of the survey tool, respondents were able to look at the
advertisement while answering questions. The result of this is that the answers may not
have been a good indicator of the actual retention of information, but rather simple
interpretation of what was available. Therefore the answers are not a good measure of
retention. Future research should prevent respondents from viewing the form after a
certain time in order to measure this. However, if individuals are unable to answer
questions while they still have the information in front of them the likelihood of
retention is diminished.

The nature of the survey itself is likely to have had an impact on the results. Allowing
individuals to be able to review the advertisement while they answered questions does
prevent us from understanding how much information was retained. One respondent did
note that in a response saying “Just FYI as a respondent, I found myself going back to
the advertisement after reading each question and doing a scavenger hunt for the
answers to your questions, looking for information that I would not have necessarily
looked for on my own. If you want to measure what people comprehend from
advertisements, perhaps instruct the respondent to spend five minutes reading the
advertisement then switching to a new page to answer comprehension questions…
(Unknown, Post-Baccalaureate).” I would agree with this respondent; however what
the survey does tell us is how much information people can garner while they still have
the advertisement at their disposal. One could assume that if a respondent could not
answer accurately when they still had the advertisement, the respondent would be less
likely to answer correctly based on recollection.
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Because respondents were allowed to take the survey on their own, there may be other
impacts to the results. As previously noted, several respondents admitted to using an
internet search to help them find answers. It is also possible that respondents had help
from colleagues or other persons near them at the time they took the survey. The
decision was made not to limit time or location of the survey in order to provide privacy
and security to respondents. However, by not monitoring their activity it is possible that
the answers provided are not an accurate reflection of each individual’s true
comprehension.

This sample was skewed toward highly educated individuals. As a result this may not
be an accurate measure of the general population. However, if it is clear that a group of
highly educated individuals has difficulty understanding the information it is likely that
less educated groups may have similar if not more exaggerated difficulties.

In order to group answers coding exercises were completed on several questions. By
codifying answers there is a certain resolution lost in analysis. Every effort was made to
mention unique or specific answers in the discussion but it is likely that some specific
knowledge is not accounted for here. All answers to free text questions (blinded and
randomized) are presented in Appendix B.

The content of the survey instrument itself could be improved for future research. The
wording of several questions and their order may be improved upon to glean different
responses. Only one test was presented to the respondents and one test is certainly not
indicative of all genetic testing. However, the test was chosen with care as a
representative of a disorder with which many people are at least somewhat familiar and
one that may have genetic and environmental components.
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CONCLUSION
Necessarily, policy consistently lags behind technological innovations. It is impossible
to determine the unintended consequences of a given technology before its widespread
adaptation. There are often both positive and negative impacts of any new technology
and it is unlikely that DTC genetic testing will be any different. That said, given the
potential health impacts at both individually and at a population level, it is critical that
we attempt to anticipate and mitigate any potential negative consequences of this
technology. Ensuring consumers have the best possible knowledge is the first step in
that process.

This research provides the first look at this issue and informs us that in a relatively well
educated population there are discrepancies in the understanding of one particular
advertisement. However there is still much work to be done in order to determine
whether regulation is necessary at a national level. Outstanding issues include
reviewing similar advertisements and websites with consumers, establishing the
retention of the information by consumers and determining what political and economic
tolerance may be for including gatekeepers in the process of obtaining genetic
information. Further studies should focus on these topics to help determine if policies
are required for these tests.

Genetic testing is currently being adopted by individuals but it may be that those
individuals do not understand the implications of this new technology. It is clear that
further research is needed to better understand how individuals interpret genetic testing
advertisement. However, based on the information presented here, it appears reasonable
that some policy measures be put in place to assist consumers in processing this
information. Just as with prescription drugs it may be important to regulate not only
what information is presented to the public, but also how that information is presented.
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Currently, the FDA is moving towards some form of regulation in this arena. Letters
have been sent to major manufacturers requesting changes be made to their advertising
practices but to date, no serious interventions have been undertaken. Information similar
to what is presented here has the opportunity to inform those decisions in a meaningful
way. While this research is limited in scope, it does indicate that there is reason to move
forward with larger and more complex studies in a similar manner. National policy
measures requiring communication with a licensed professional may be the most
palatable and effective step to regulating these tests.
At least in this population, there is a disconnect between an individual’s perceived
expertise and their true understanding of the information presented in this advertisement.
Because this population has a higher average education than the general population we
can presume that this trend may prove true or indeed worsen in a broader sample. In
general it appears that this population believes they have a better understanding of the
information than they actually do. In addition a definitive line needs to be drawn in
terms of what patients actually need to know and at what level they need to understand
this information. Given the major decisions that can be made based on the results of
these tests, a fundamental misunderstanding of their meaning may be devastating to a
patient’s health in the long-term.

Whether or not government regulation is required in this arena is dependent upon a
multitude of factors, including consumer understanding, consumer decision making, and
health outcomes as a result of those decisions. Any break in this chain could result in a
devastating impact to individual and public health. This research focuses on the first
link in that chain and indicates that there is a need for further work. Without adequate
patient understanding the other two links are necessarily impacted as misinformed
decisions can be quite dangerous especially when it comes to a person’s health. This
research indicates that there is a good possibility that individuals who purchase these
tests without further guidance are currently misinformed and would benefit from an
increased regulatory structure requiring clear communication and personalized
intervention from knowledgeable health care professionals.
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Appendix A - Survey Instrument
RIT Home | RIT A-Z Index | RIT Search | myRIT

My Surveys

Help

Welcome, Albert Blankley ( logout )

Direct-to-Consumer Genetic Testing
You are invited to join a research study which looks at Direct-to-consumer (DTC) genetic testing. In this research study, we are investigating how people
understand information presented to consumers by DTC genetic testing companies.
You will be asked to complete a short survey, in which you will be presented with a screenshot from a website and asked questions about the information
presented, as well as some demographic questions and some questions relating to your background in biological science. We think this will take you
between 5 and 10 minutes.
You may stop participating at any time. If you decide to leave the study simply close the window in which the survey is presented.
CONFIDENTIALITY
Your name will not be used when data from this study are published. All survey results are anonymous and are not linked to a specific user. Every effort will
be made to keep all personal information confidential. As the primary investigator, only Albert Blankley will have access to the data and there is no link
between who responded to the survey and the specific answers you provide.
Participation in this study is voluntary. You have the right not to participate at all or to leave the study at any time. Deciding not to participate or choosing to
leave the study will not result in any penalty or loss of benefits to which you are entitled.
If you have any questions or concerns please feel free to contact me at aab8038@rit.edu.
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Demographics

1. What is your age?

2. What is your sex?
Male
Female
Other

3. Education (please select one):
Some High-school
Graduated High-school
Attended some college
Associate's degree
Bachelor's degree

4. If you have a received a college education (associate's or more) please indicate your major

5. What is your highest terminal degree?

6. What is your current occupation?

7. Ethnicity
African American
Asian / Pacific Islander
Caucasian
Latin / South American
Native American
Other:
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Interpretation Questions

8. What are your impressions of alcohol dependency and genetics

9. How many studies are described by this advertisement?

10. If you had a family member who had a dependency on alcohol would you be interested in getting a genetic test for
yourself?
Yes
No

11. If you had a blood relative who had a dependency on alcohol would you be interested in getting a genetic test for
yourself?
Yes
No

12. What is the relationship between marker RS27072 and alcohol dependency?

13.
Not
Closely At
All (1)

Not Very
Closely
(2)

Somewhat
Closely
(3)

Fairly
Closely
(4)

Very
Closely
(5)

How closely are genes and alcohol dependency related?

14. Does ethnicity have an impact on this relationship?
Yes
No

15. If so, how?
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16.
Very
uninterested

Not
Interested

Neutral

Somewhat
Interested

Very
interested

How interested are you in this condition?

17. Approximately how many people’s genetics were studied to determine the relationship between marker
RS18001197 and alcohol dependency?
10
100
1000
10000

18. What would you do if you received a test result that indicated you had this gene?
✔

Nothing

✔

Seek more information on the condition on the internet

✔

Talk to my doctor about my risks

✔

Call the company to speak to a genetic counselor

19. Where did you receive the majority of the information?
Charts
Graphs
Numbers
Text
Photos

Science Background

20. What is an established research report?
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21. What journals did the research stem from?

22. What is a SNP?

23. Susie requested that this analysis be done for her. The result stated that she had an increased risk for alcohol
dependency. The letter from the lab said that her test was ____________.
Positive
Negative
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